Nantahala Capital Management, LLC 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management, LLC | 2,507,125 5.730% |
-1,170,614 (-31.83%) |
Filing |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management, LLC | 3,677,739 9.990% |
447,836 (+13.87%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Nantahala Capital Management, LLC | 3,229,903 9.900% |
3,229,903 (New Position) |
Filing |